Atlas Trials

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Clinical trial NCT00089128 · TERMINATED

Trial details

NCT number
NCT00089128
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2001-11-01
Primary completion
2008-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.